Soliton

Soliton is developing game-changing science to address multiple multibillion-dollar market opportunities. They spent over 25 million dollars over the past 5 years developing a breakthrough technology that dramatically accelerates the removal of tattoos. Their devices use very high energy, in the range of 3,000 volts at nearly 3,000 amps, to form acoustic shockwaves at 100 times per second.  Soliton's core team is comprised of life science veterans, with more than 150 years of life science experience, multiple device clearances, and multiple national and international aesthetic device launches.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Soliton is developing a breakthrough technology for tattoo removal and cellulite treatment which will save time and money and have a higher degree of efficiency.

Soliton: Risks Exist But Potential Is Well Worth A Serious Look

Why Soliton Stock Is Falling Today

Medical device company Soliton Inc. (NASDAQ: SOLY) shares are trading higher again after the company highlighted its preclinical results for its new RAP device, which "is a potentially important new way to treat cellulite and improve the appearance of the skin.

Soliton Higher Following Preclinical Results For New Version Of Acoustic Pulse Device

The company is riding high following FDA clearance for its tattoo removal medical device.

Why Soliton's Shares Went on a Roller Coaster Ride Today

Medical device company Soliton Inc. shares are trading higher again after the company announced its decision to move forward with a pivotal trial after positive data from its proof-of-concept trial to reduce cellulite.

Momentum Stock Soliton Continues Rally Following News Of Cellulite Trial Initiation

Approval from the U.S. Food and Drug Administration (FDA) for a Soliton tattoo removal device has SOLY stock on the rise Wednesday.

Soliton Tattoo Removal Device: SOLY Stock Skyrockets on FDA Approval

Medical device company Soliton Inc. has received FDA 510(k) approval for its acoustic wave device for dermal tattoo clearing.

Soliton Rallies On FDA Approval For Tattoo Removal Device

There is no guarantee Soliton’s RAP technology will be able to penetrate the tattoo removal market.

Soliton, Inc: A Bright Future Or A Perpetual Debt Machine?

News for Soliton Stock (SOLY)